Dallas, PA
Chelation Therapy clinics in Dallas
Chelation therapy in Dallas is offered by a small set of integrative and naturopathic clinics, typically for documented heavy metal toxicity confirmed by provocation or baseline testing. Common agents include calcium disodium EDTA, DMPS, DMSA, and deferoxamine, each with specific binding profiles for lead, mercury, arsenic, or iron.
Most Dallas chelation providers are MDs or DOs with ACAM training, and in some states naturopathic doctors within their licensed scope. Protocols vary from 10-session courses for basic detoxification to longer 30-session cardiovascular protocols modeled on the TACT trial. Pricing is cash-pay in almost every case, and no insurance covers off-label chelation.
With verified chelation therapy clinics on Regenerated.com in Dallas, Texas, patients can compare provider credentials, testing protocols, and agent selection. Regenerated.com does not recommend chelation for cardiovascular disease or autism. The FDA has only approved specific agents for specific heavy metal poisoning diagnoses. Chelation outside that narrow indication is off-label, and in the wrong hands it has caused deaths.
No clinics found
Reset all filtersRegulatory context
A note on Pennsylvania's chelation therapy rules.
The FDA has approved a narrow set of chelating agents for specific heavy metal toxicities. Calcium disodium edetate (CaNa2EDTA, Versenate) is approved for symptomatic lead poisoning, succimer (Chemet, DMSA) for pediatric lead poisoning at blood lead levels above 45 mcg/dL, deferoxamine (Desferal) and deferasirox (Exjade) for chronic iron overload, and dimercaprol (BAL) for arsenic, gold, and acute lead poisoning. Use of EDTA chelation for cardiovascular disease was studied in the NIH-funded TACT trial (2013) with controversial findings and remains not FDA-approved for that indication. Chelation for autism spectrum disorder is not evidence-based and has been linked to pediatric deaths. The FDA issued a 2010 sweep of warning letters to compounders marketing OTC chelation products with unapproved disease claims.
-
Pennsylvania Medical Practice Act of 1985, 63 P.S. Section 422
Governs MD practice in Pennsylvania. -
Pennsylvania Osteopathic Medical Practice Act, 63 P.S. Section 271
Governs DO practice in Pennsylvania.
Pennsylvania is the location of the 2005 Pittsburgh pediatric chelation death, in which a five-year-old autistic boy died after receiving Na2EDTA (the wrong EDTA salt) instead of CaNa2EDTA. This case shaped national board guidance on chelation safety and pediatric protocols. The Pennsylvania State Board of Medicine has investigated chelation practitioners for marketing claims tied to autism and cardiovascular disease. Pennsylvania does not license NDs. Philadelphia and Pittsburgh have moderate integrative medicine communities.
Chelation Therapy in Dallas, answered.
Explore related care